Skip to main content
Top
Published in: Clinical Drug Investigation 5/2010

01-05-2010 | Original Research Article

Quality of Drug Prescribing in Elderly People in Nursing Homes and Special Care Units for Dementia

A Cross-Sectional Computerized Pharmacy Register Analysis

Authors: Dr Jonny Olsson, Åsa Bergman, Anders Carlsten, Thimothy Oké, Cecilia Bernsten, Ingrid K. Schmidt, Johan Fastbom

Published in: Clinical Drug Investigation | Issue 5/2010

Login to get access

Abstract

Background: Drug prescribing to the elderly is extensive and often inappropriate. Furthermore, the number of drugs used is the most important risk factor for adverse drug reactions. Despite this, drug prescribing in the elderly in Sweden is high and increasing. In 2003 the Swedish National Board of Health and Welfare launched a set of indicators to evaluate the quality of drug therapy in the elderly. Use of this tool in combination with the Swedish computerized national register covering all persons receiving multi-dose drug dispensing (drugs dispensed in one dose unit bag for each dose occasion) would enable detection of inappropriate drug prescribing and could help reduce the risk of drug-related problems among the elderly.
Objectives: To assess the extent and quality of drug prescribing in younger and older elderly residents receiving multi-dose drug dispensing in ordinary nursing homes (NHs) and special care units for dementia (NHDs), and to evaluate the relationship between the quality of prescribing and the number of prescribers per resident, in a Swedish county.
Methods: The computerized national pharmacy drug register provided the database and a cross-sectional design was used. Selected drug-specific quality indicators proposed by the Swedish National Board of Health and Welfare in 2003 were used to assess the quality of drug prescribing.
Results: This study included 3705 residents. Their mean age was 85 years and 72% were women. The mean number of prescribed drugs was 10.3 per resident. The proportion of residents with prescriptions for psychotropic drugs was 80% in NHs and 85% in NHDs. The prevalence of each drug-specific quality indicator was as follows: long-acting benzodiazepines 16.4% (NHs) versus 11.7% (NHDs), anticholinergic drugs 20.7% versus 18.5%, drug duplication 14.6% versus 13.6%, three or more psychotropic drugs 25.6% versus 35.3%, class C interactions (drug combinations that may require dose adjustment) 41.9% versus 38.7% and class D interactions (drug combinations that should be avoided) 8.1% versus 5.6%. Younger elderly residents (age 65–79 years) had a lower quality of drug prescribing. An increasing number of prescribers per resident was associated with a lower quality of drug therapy.
Conclusions: We found a lower quality of drug prescribing, e.g. anticholinergic drugs prescribed to approximately 20% of residents of NHs and NHDs, and a higher rate of psychotropic drug use (≥80%) compared with previous studies in NHs. Our results also demonstrated a negative correlation between quality of prescribing and number of prescribers per resident.
Literature
1.
go back to reference Stewart RB, Cooper JW. Polypharmacy in the aged: practical solutions. Drugs Aging 1994; 4(6): 449–61PubMedCrossRef Stewart RB, Cooper JW. Polypharmacy in the aged: practical solutions. Drugs Aging 1994; 4(6): 449–61PubMedCrossRef
2.
go back to reference Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123: 195–204PubMed Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123: 195–204PubMed
3.
go back to reference Williams B, Betley C. Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc 1995; 43(5): 513–9PubMed Williams B, Betley C. Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc 1995; 43(5): 513–9PubMed
4.
go back to reference National Board of Health and Welfare. Läkemedel på sjukhem [Drug use in nursing homes].The National Board of Health and Welfare Follows Up and Evaluates, 1996; 1 [in Swedish]. Stockholm: National Board of Health and Welfare, 1996 National Board of Health and Welfare. Läkemedel på sjukhem [Drug use in nursing homes].The National Board of Health and Welfare Follows Up and Evaluates, 1996; 1 [in Swedish]. Stockholm: National Board of Health and Welfare, 1996
5.
go back to reference Spore DL. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997; 87: 404–9PubMedCrossRef Spore DL. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997; 87: 404–9PubMedCrossRef
6.
go back to reference Giron MST, Claesson C, Thorslund M, et al. Drug use patterns in a very elderly population: a seven-year review. Clin Drug Investig 1999; 17(5): 389–98CrossRef Giron MST, Claesson C, Thorslund M, et al. Drug use patterns in a very elderly population: a seven-year review. Clin Drug Investig 1999; 17(5): 389–98CrossRef
7.
go back to reference Schmidt IK, Fastbom J. Quality of drug use in Swedish nursing homes: a follow-up study. Clin Drug Investig 2000; 20: 433–46CrossRef Schmidt IK, Fastbom J. Quality of drug use in Swedish nursing homes: a follow-up study. Clin Drug Investig 2000; 20: 433–46CrossRef
8.
go back to reference Giron MST, Wang H-X, Bernsten C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001; 49: 277–83PubMedCrossRef Giron MST, Wang H-X, Bernsten C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001; 49: 277–83PubMedCrossRef
9.
go back to reference Dhalla IA, Anderson GM, Mamdani MM, et al. Inappropriate prescribing before and after nursing home admission. J Am Geriatr Soc 2002; 50: 995–1000PubMedCrossRef Dhalla IA, Anderson GM, Mamdani MM, et al. Inappropriate prescribing before and after nursing home admission. J Am Geriatr Soc 2002; 50: 995–1000PubMedCrossRef
10.
go back to reference Pittrow D, Krappweis J, Rentsch A, et al. Pattern of prescriptions issued by nursing home-based physicians versus office-based physicians for frail elderly patients in German nursing homes. Pharmacoepidemiol Drug Saf 2003; 12(7): 595–9PubMedCrossRef Pittrow D, Krappweis J, Rentsch A, et al. Pattern of prescriptions issued by nursing home-based physicians versus office-based physicians for frail elderly patients in German nursing homes. Pharmacoepidemiol Drug Saf 2003; 12(7): 595–9PubMedCrossRef
11.
go back to reference Fastbom J, Schmidt IK. Shortages in the treatment of depression of the elderly in nursing homes in Stockholm: diagnosis is based on flimsy ground, follow up performed rarely. J Swedish Med Assoc (Läkartidningen) 2004; 101(46): 3683–8 Fastbom J, Schmidt IK. Shortages in the treatment of depression of the elderly in nursing homes in Stockholm: diagnosis is based on flimsy ground, follow up performed rarely. J Swedish Med Assoc (Läkartidningen) 2004; 101(46): 3683–8
12.
go back to reference Kragh A. Two out of three persons living in nursing homes for the elderly are treated with at least ten different drugs: a survey of drug prescriptions in the northeastern part of Skane [in Swedish]. J Swedish Med Assoc (Läkartidningen) 2004 Mar 11; 101(11): 994–6, 999 Kragh A. Two out of three persons living in nursing homes for the elderly are treated with at least ten different drugs: a survey of drug prescriptions in the northeastern part of Skane [in Swedish]. J Swedish Med Assoc (Läkartidningen) 2004 Mar 11; 101(11): 994–6, 999
13.
go back to reference Lane CJ, Bronskill SE, Sykora K, et al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc 2004; 52: 861–6PubMedCrossRef Lane CJ, Bronskill SE, Sykora K, et al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc 2004; 52: 861–6PubMedCrossRef
14.
go back to reference Perri3rd M, Menon AM, Desphande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005 Mar; 39(3): 405–11PubMedCrossRef Perri3rd M, Menon AM, Desphande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005 Mar; 39(3): 405–11PubMedCrossRef
15.
go back to reference Johnell K, Fastbom J. Multi-dose drug dispensing and inappropriate drug use: a nationwide register-based study of over 700,000 elderly. Scand J Prim Health Care 2008; 26(2): 86–91PubMedCrossRef Johnell K, Fastbom J. Multi-dose drug dispensing and inappropriate drug use: a nationwide register-based study of over 700,000 elderly. Scand J Prim Health Care 2008; 26(2): 86–91PubMedCrossRef
16.
go back to reference Nolan L, Malley K. Prescribing for the elderly. Part I: sensitivity of the elderly to adverse drug reactions.J Am Geriatr Soc 1988; 36: 142–9PubMed Nolan L, Malley K. Prescribing for the elderly. Part I: sensitivity of the elderly to adverse drug reactions.J Am Geriatr Soc 1988; 36: 142–9PubMed
17.
go back to reference Tsujimoto G, Hashimoto K, Hoffman BB. Pharmacokinetic and pharmacodynamic principles of drug therapy in old age: part 1. Int J Clin Pharmacol Ther Toxicol 1989; 27(1): 13–26PubMed Tsujimoto G, Hashimoto K, Hoffman BB. Pharmacokinetic and pharmacodynamic principles of drug therapy in old age: part 1. Int J Clin Pharmacol Ther Toxicol 1989; 27(1): 13–26PubMed
18.
go back to reference Tsujimoto G, Hashimoto K, Hoffman BB. Pharmacokinetic and pharmacodynamic principles of drug therapy in old age: part 2. Int J Clin Pharmacol Ther Toxicol 1989; 27(3): 102–16PubMed Tsujimoto G, Hashimoto K, Hoffman BB. Pharmacokinetic and pharmacodynamic principles of drug therapy in old age: part 2. Int J Clin Pharmacol Ther Toxicol 1989; 27(3): 102–16PubMed
19.
20.
go back to reference Cancelli I, Beltrame M, Gigli GL, et al. Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. Neurol Sci 2009; 30(2): 87–92PubMedCrossRef Cancelli I, Beltrame M, Gigli GL, et al. Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. Neurol Sci 2009; 30(2): 87–92PubMedCrossRef
22.
go back to reference Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14(2): 141–52PubMedCrossRef Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14(2): 141–52PubMedCrossRef
23.
go back to reference Walker J, Wynne H. The frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994; 23: 255–9PubMedCrossRef Walker J, Wynne H. The frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994; 23: 255–9PubMedCrossRef
24.
go back to reference Beard K. Adverse reactions as a cause of hospital admission in the aged. Drugs Aging 1992; 2(4): 356–67PubMedCrossRef Beard K. Adverse reactions as a cause of hospital admission in the aged. Drugs Aging 1992; 2(4): 356–67PubMedCrossRef
25.
go back to reference Sarlov C, Andersén-Karlsson E, von Bahr C. Adverse effects of drugs in patients with heart disease lead to hospital care [in Swedish]. J Swedish Med Assoc (Läkartidningen) 2001; 47: 5349–53 Sarlov C, Andersén-Karlsson E, von Bahr C. Adverse effects of drugs in patients with heart disease lead to hospital care [in Swedish]. J Swedish Med Assoc (Läkartidningen) 2001; 47: 5349–53
26.
go back to reference Beijer HJ, deBlaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24(2): 46–54PubMedCrossRef Beijer HJ, deBlaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24(2): 46–54PubMedCrossRef
27.
go back to reference Mjorndal T, Boman MD, Hägg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002; 11(1): 65–72PubMedCrossRef Mjorndal T, Boman MD, Hägg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002; 11(1): 65–72PubMedCrossRef
28.
go back to reference Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 2005; 22(1): 69–82PubMedCrossRef Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 2005; 22(1): 69–82PubMedCrossRef
29.
go back to reference Douglas IJ, Smeeth L. Exposure to antipsychotics and the risk of stroke; self controlled case series study. BMJ 2008; 337: a1227PubMedCrossRef Douglas IJ, Smeeth L. Exposure to antipsychotics and the risk of stroke; self controlled case series study. BMJ 2008; 337: a1227PubMedCrossRef
30.
go back to reference Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360(3): 225–35PubMedCrossRef Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360(3): 225–35PubMedCrossRef
31.
go back to reference The National Board of Health and Welfare (Socialstyrelsen, Stockholm, Sweden). Indikatorer för utvärdering av kva-liteten i äldres läkemedelsterapi: socialstyrelsens förslag. Stockholm: Socialstyrelsen, 2003 The National Board of Health and Welfare (Socialstyrelsen, Stockholm, Sweden). Indikatorer för utvärdering av kva-liteten i äldres läkemedelsterapi: socialstyrelsens förslag. Stockholm: Socialstyrelsen, 2003
32.
go back to reference Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531–6PubMedCrossRef Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531–6PubMedCrossRef
33.
go back to reference Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716–24PubMedCrossRef Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716–24PubMedCrossRef
34.
go back to reference McLeod PJ. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 385–91PubMed McLeod PJ. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 385–91PubMed
35.
go back to reference Oborne CA, Batty GM, Maskrey V, et al. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91–7PubMedCrossRef Oborne CA, Batty GM, Maskrey V, et al. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91–7PubMedCrossRef
36.
go back to reference Bergman A, Olsson J, Carlsten A, et al. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 2007 Mar; 25(1): 9–14PubMedCrossRef Bergman A, Olsson J, Carlsten A, et al. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 2007 Mar; 25(1): 9–14PubMedCrossRef
37.
go back to reference Giron MST, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16: 900–6PubMedCrossRef Giron MST, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16: 900–6PubMedCrossRef
38.
go back to reference Nilsson L, Petersson C. Consumption of psychopharmaceuticals in residential facilities for the elderly: evaluation of the extent, indications and effects [in Swedish]. J Swedish Med Assoc (Läkartidningen) 2001; 98: 1371–73 Nilsson L, Petersson C. Consumption of psychopharmaceuticals in residential facilities for the elderly: evaluation of the extent, indications and effects [in Swedish]. J Swedish Med Assoc (Läkartidningen) 2001; 98: 1371–73
39.
go back to reference Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes: diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57: 523–8PubMedCrossRef Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes: diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57: 523–8PubMedCrossRef
40.
go back to reference Wolf-Klein GP, Siverstone FA, Brod MS, et al. Are Alzheimer patients healthier? J Am Geriatr Soc 1988; 36(3): 219–24PubMed Wolf-Klein GP, Siverstone FA, Brod MS, et al. Are Alzheimer patients healthier? J Am Geriatr Soc 1988; 36(3): 219–24PubMed
41.
go back to reference Gobert M, D’hoore W. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatry 2005 Aug; 20(8): 712–21PubMedCrossRef Gobert M, D’hoore W. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatry 2005 Aug; 20(8): 712–21PubMedCrossRef
42.
go back to reference Mann E, Köpke S, Haastert B, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009; 9: 18PubMedCrossRef Mann E, Köpke S, Haastert B, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009; 9: 18PubMedCrossRef
43.
go back to reference Schatzberg AF, Kremer C, Rodrigues HE, et al. Doubleblind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry 2002; 10: 541–50PubMed Schatzberg AF, Kremer C, Rodrigues HE, et al. Doubleblind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry 2002; 10: 541–50PubMed
44.
go back to reference Sweet RA, Pollock BG. New atypical antipsychotics: experience and utility in the elderly. Drugs Aging 1998; 12(2): 115–27PubMedCrossRef Sweet RA, Pollock BG. New atypical antipsychotics: experience and utility in the elderly. Drugs Aging 1998; 12(2): 115–27PubMedCrossRef
46.
go back to reference Fastbom J. Treatment issues in elderly patients with Alzheimer’s disease. Alzheimer Insights 1998; 4: 7–10 Fastbom J. Treatment issues in elderly patients with Alzheimer’s disease. Alzheimer Insights 1998; 4: 7–10
47.
go back to reference National Board of Health and Welfare. The quality of the drug use in elderly people [in Swedish]. The National Board of Health and Welfare Follows Up and Evaluates, 2000: 8. Stockholm: National Board of Health and Welfare, 2000 National Board of Health and Welfare. The quality of the drug use in elderly people [in Swedish]. The National Board of Health and Welfare Follows Up and Evaluates, 2000: 8. Stockholm: National Board of Health and Welfare, 2000
48.
go back to reference Campbell AJ. Drug treatment as a cause of falls in old age: a review of the offending agents. Drugs Aging 1991; 1(4): 289–302PubMedCrossRef Campbell AJ. Drug treatment as a cause of falls in old age: a review of the offending agents. Drugs Aging 1991; 1(4): 289–302PubMedCrossRef
49.
go back to reference Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis. I. Psychotropic drugs. J Am Geriatr Soc 1999; 47(1): 30–9PubMed Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis. I. Psychotropic drugs. J Am Geriatr Soc 1999; 47(1): 30–9PubMed
50.
go back to reference FASS (Pharmaceutical Specialities in Sweden) [in Swedish]. Stockholm: LINFO Läkemedelsinformation AB, 2003 FASS (Pharmaceutical Specialities in Sweden) [in Swedish]. Stockholm: LINFO Läkemedelsinformation AB, 2003
51.
go back to reference Nygaard HA, Naik M, Ruths S, et al. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents. The Bergen District Nursing Home (BEDNURS) study. Eur J Clin Pharmacol 2003; 59: 463–9PubMedCrossRef Nygaard HA, Naik M, Ruths S, et al. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents. The Bergen District Nursing Home (BEDNURS) study. Eur J Clin Pharmacol 2003; 59: 463–9PubMedCrossRef
52.
go back to reference Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652–8PubMedCrossRef Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652–8PubMedCrossRef
53.
go back to reference Preskorn SH, Silkey B, Shah R, et al. Complexity of medication use in the Veterans Affairs Healthcare System. Part 1: outpatient use in relation to age and number of prescribers. J Psychiatr Pract 2005; 11:5–15PubMedCrossRef Preskorn SH, Silkey B, Shah R, et al. Complexity of medication use in the Veterans Affairs Healthcare System. Part 1: outpatient use in relation to age and number of prescribers. J Psychiatr Pract 2005; 11:5–15PubMedCrossRef
Metadata
Title
Quality of Drug Prescribing in Elderly People in Nursing Homes and Special Care Units for Dementia
A Cross-Sectional Computerized Pharmacy Register Analysis
Authors
Dr Jonny Olsson
Åsa Bergman
Anders Carlsten
Thimothy Oké
Cecilia Bernsten
Ingrid K. Schmidt
Johan Fastbom
Publication date
01-05-2010
Publisher
Springer International Publishing
Published in
Clinical Drug Investigation / Issue 5/2010
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI
https://doi.org/10.2165/11534320-000000000-00000

Other articles of this Issue 5/2010

Clinical Drug Investigation 5/2010 Go to the issue